Abstract:The incidence of malignant melanoma is increasing worldwide. If detected early, melanoma is highly treatable, so early detection is vital.Skin cancer early detection has improved significantly in recent decades, for example by the introduction of screening in 2008 and dermoscopy. Nevertheless, in particular visual detection of early melanomas remains challenging because they show many morphological overlaps with nevi. Hence, there continues to be a high medical need to further develop methods for early skin cancer detection in order to be able to reliably diagnosemelanomas at a very early stage.Routine diagnostics for melanoma detection include visual whole body inspection, often supplemented by dermoscopy, which can significantly increase the diagnostic accuracy of experienced dermatologists. A procedure that is additionally offered in some practices and clinics is wholebody photography combined with digital dermoscopy for the early detection of malignant melanoma, especially for monitoring high-risk patients.In recent decades, numerous noninvasive adjunctive diagnostic techniques were developed for the examination of suspicious pigmented moles, that may have the potential to allow improved and, in some cases, automated evaluation of these lesions. First, confocal laser microscopy should be mentioned here, as well as electrical impedance spectroscopy, multiphoton laser tomography, multispectral analysis, Raman spectroscopy or optical coherence tomography. These diagnostic techniques usually focus on high sensitivity to avoid malignant melanoma being overlooked. However, this usually implies lower specificity, which may lead to unnecessary excision of benign lesions in screening. Also, some of the procedures are time-consuming and costly, which also limits their applicability in skin cancer screening. In the near future, the use of artificial intelligence might change skin cancer diagnostics in many ways. The most promising approach may be the analysis of routine macroscopic and dermoscopic images by artificial intelligence.For the classification of pigmented skin lesions based on macroscopic and dermoscopic images, artificial intelligence, especially in form of neural networks, has achieved comparable diagnostic accuracies to dermatologists under experimental conditions in numerous studies. In particular, it achieved high accuracies in the binary melanoma/nevus classification task, but it also performed comparably well to dermatologists in multiclass differentiation of various skin diseases. However, proof of the basic applicability and utility of such systems in clinical practice is still pending. Prerequisites that remain to be established to enable translation of such diagnostic systems into dermatological routine are means that allow users to comprehend the system's decisions as well as a uniformly high performance of the algorithms on image data from other hospitals and practices.At present, hints are accumulating that computer-aided diagnosis systems could provide their greatest benefit as assistance systems, since studies indicate that a combination of human and machine achieves the best results. Diagnostic systems based on artificial intelligence are capable of detecting morphological characteristics quickly, quantitatively, objectively and reproducibly, and could thus provide a more objective analytical basis - in addition to medical experience.

BT30 Artificial intelligence triage is of greater benefit for screening suspected melanoma referrals than squamous cell carcinoma referrals

BT06 Using artificial intelligence to triage skin cancer referrals: outcomes from a pilot study

BT09 Clinical performance of an artificial intelligence-based medical device deployed within an urgent suspected skin cancer pathway

BT09 Multicentre prospective clinical performance analysis of an artificial intelligence as a medical device deployed within urgent suspected skin cancer pathways

Accuracy of an artificial intelligence as a medical device as part of a UK-based skin cancer teledermatology service

Artificial Intelligence Support for Skin Lesion Triage in Primary Care and Dermatology

Artificial Intelligence-Based Triaging of Cutaneous Melanocytic Lesions

Artificial Intelligence Support for Skin Lesion Triage in Primary Care and Dermatology (Preprint)

BT05 Comparing the number-needed-to-biopsy ratio for melanoma diagnosis between teledermatology, an artificial intelligence device with teledermatology, and face-to-face models of care

BT12 Great expectations: implementing artificial intelligence software into a regional skin cancer teledermatology service

BT29 Modelling the cost-effectiveness of an artificial intelligence as a medical device

Testing Artificial Intelligence Algorithms in the Real World: Lessons From the SMARTI Trial

Patient and dermatologists' perspectives on augmented intelligence for melanoma screening: A prospective study

Evaluation of an artificial intelligence-based decision support for detection of cutaneous melanoma in primary care – a prospective, real-life, clinical trial

Analysis of Artificial Intelligence-Based Approaches Applied to Non-Invasive Imaging for Early Detection of Melanoma: A Systematic Review

Artificial intelligence and skin melanoma

Patient perspectives of artificial intelligence as a medical device in a skin cancer pathway

[The Rise of Artificial Intelligence - High Prediction Accuracy in Early Detection of Pigmented Melanoma]

Clinical Melanoma Diagnosis with Artificial Intelligence: Insights from a Prospective Multicenter Study

Teledermatology & Digital Dermatology SymposiumOral presentationsBT01 Developing a national artificial intelligence-assisted skin cancer pathway

Prospective validation of dermoscopy-based open-source artificial intelligence for melanoma diagnosis (PROVE-AI study)